AVITA Medical (RCEL) Invested Capital (2019 - 2025)
AVITA Medical (RCEL) has disclosed Invested Capital for 6 consecutive years, with $26.3 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Invested Capital rose 485.33% year-over-year to $26.3 million, compared with a TTM value of $26.3 million through Dec 2025, up 485.33%, and an annual FY2025 reading of $26.3 million, up 485.33% over the prior year.
- Invested Capital was $26.3 million for Q4 2025 at AVITA Medical, up from -$3.7 million in the prior quarter.
- Across five years, Invested Capital topped out at $97.8 million in Q1 2022 and bottomed at -$9.9 million in Q2 2025.
- Average Invested Capital over 4 years is $44.1 million, with a median of $40.8 million recorded in 2023.
- Peak annual rise in Invested Capital hit 485.33% in 2025, while the deepest fall reached 141.36% in 2025.
- Year by year, Invested Capital stood at $84.7 million in 2022, then tumbled by 42.11% to $49.1 million in 2023, then plummeted by 90.83% to $4.5 million in 2024, then soared by 485.33% to $26.3 million in 2025.
- Business Quant data shows Invested Capital for RCEL at $26.3 million in Q4 2025, -$3.7 million in Q3 2025, and -$9.9 million in Q2 2025.